The global Glucose Meter Market was valued at USD 9.50 Billion in 2021 and is projected to experience a compound annual growth rate (CAGR) of 9.5% during the forecast period. Factors such as the increasing number of individuals with diabetes worldwide, rising awareness about diabetes prevention, advancements in healthcare technology, and frequent introduction of innovative glucose monitoring meters and devices are expected to contribute to the growth of market revenue.
According to the International Diabetes Federation, around 537 million people between the ages of 20 and 79 had diabetes in 2021. This number is expected to reach 643 million by 2030 and 783 million by 2045. Three out of every four adults in low- or middle-income countries are affected by diabetes, with nearly half of them (240 million) remaining undiagnosed. In 2021 alone, diabetes caused 6.7 million deaths and resulted in significant healthcare expenses. Additionally, 21 million pregnancies were impacted by diabetes, and a total of 541 million adults were at a higher risk of developing type 2 diabetes. This substantial increase in the global diabetes rate has led to a growing demand for treatment devices and prevention strategies. Monitoring blood glucose levels is crucial for managing diabetes as it helps determine the appropriate timing and dosage of insulin. Both hyperglycemia (high blood sugar) and hypoglycemia (low blood sugar) can be dangerous and potentially fatal if not addressed promptly. While diabetes can affect individuals of any age, it is more prevalent among children and young adults. The increasing need for blood glucose monitoring among individuals with type 1 and type 2 diabetes is driving the demand for glucose meters. Type 1 diabetes requires daily insulin treatment, regular monitoring of blood glucose levels, and a healthy lifestyle for effective management.
Get a sample of the report @ https://www.reportsanddata.com/download-free-sample/95
Competitive Landscape:
Some major companies profiled in the global market report include F. Hoffmann-La Roche AG, Abbott Laboratories, Ascensia Diabetes Care, Medtronic PLC, LifeScan Inc., Nova Biomedical Corporation, OMRON Corporation, Nipro Medical Corporation, ACON Laboratories Inc., Prodigy Diabetes Care LLC., B. Braun Melsungen AG, Dexcom Inc., Ypsomed AG, Sanofi SA, Hainice Medical Inc., and Sannuo Biological Sensing Co., Ltd.
To know more about the report @ https://www.reportsanddata.com/report-detail/glucose-meter-market
Factors Driving the Glucose Meter Market:
- Increase in Diabetic Population: The rising prevalence of diabetes globally is a significant driver for the glucose meter market. The growing number of individuals diagnosed with diabetes creates a higher demand for glucose monitoring devices.
- Awareness about Diabetes Management: There has been an increase in awareness about the importance of managing diabetes effectively. People are now more conscious about monitoring their blood glucose levels regularly, leading to a higher adoption of glucose meters.
- Technological Advancements: Continuous advancements in healthcare technology have led to the development of more innovative and user-friendly glucose meters. Features such as wireless connectivity, smartphone integration, and improved accuracy have attracted consumers, boosting the market growth.
- Launch of Innovative Products: The market has witnessed frequent launches of new and innovative glucose monitoring meters and devices. These advancements provide enhanced functionalities, improved convenience, and better data management, driving market growth.
Factors Restraining the Glucose Meter Market:
- Cost of Glucose Meters: High costs associated with glucose meters and their consumables can be a restraining factor, especially in low- and middle-income countries. The affordability of these devices may limit their adoption, hindering market growth.
- Lack of Reimbursement: In some regions, the lack of adequate reimbursement policies for glucose meters and related supplies can discourage patients from purchasing and using these devices. This reimbursement gap acts as a barrier to market growth.
- Alternative Glucose Monitoring Methods: While glucose meters are widely used, there are alternative methods for monitoring blood glucose levels, such as continuous glucose monitoring (CGM) systems. The availability and increasing popularity of these alternatives may impact the demand for traditional glucose meters.
- Limited Awareness and Accessibility: In certain regions, particularly in low-resource settings, there may be limited awareness about the benefits of glucose monitoring and limited accessibility to glucose meters. This lack of awareness and limited availability can impede market growth in these areas.
It is important to note that these factors can vary in their impact depending on the geographical region and healthcare infrastructure of a particular market.
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/95
About Us:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.
Contact Us:
John W
Head of Business Development
Direct Line: +1-212-710-1370
E-mail: [email protected]
Reports and Data | Web: www.reportsanddata.com
Check our upcoming research reports @ https://www.reportsanddata.com/upcoming-reports
Visit our blog for more industry updates @ https://www.reportsanddata.com/blogs
